RBP4 and metabolic disease: Specifically, the impact of RBP4 on various pathways associated with physiological processes such as adipogenesis and gluconeogenesis, as well as disease-promoting activities like impairing insulin signaling and causing insulin resistance during the development of diabetes, make this lipocalin an intriguing therapeutic target for combating metabolic diseases (Figure 4).